Dhira Joshi

Dhira Joshi

Auto-generated profile, based on publicly available information

Dhira Joshi

Chemical Biology Science Technology Platform, The Francis Crick Institute, London, UK

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 December 2020 in Science
Verified
Journal Article
Open access
PDF file
KNKevin W. Ng
Kevin W. Ng
NFNikhil Faulkner
Nikhil Faulkner
GCGeorgina H. Cornish
Georgina H. Cornish
ARAnnachiara Rosa
Annachiara Rosa
RHRuth Harvey
Ruth Harvey
GKGeorge Kassiotis
George Kassiotis
Antibodies predating infection: Immunological memory after infection with seasonal human coronaviruses (hCoVs) may potentially contribute to cross-protection against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Ng et al. report that in a cohort of 350 SARS-CoV-2–uninfected individuals, a small proportion had circulating immunoglobulin G (IgG) antibodies that could cross-react with the S2 subunit of the SARS-CoV-2 spike protein (see the Perspective by Guthmiller and Wilson). By contrast, COVID-19 patients generated IgA, IgG, and IgM antibodies that recognized both the S1 and S2 subunits. The anti-S2 antibodies from SARS-CoV-2–uninfected patients showed specific neutralizing activity against both SARS-CoV-2 and SARS-CoV-2 S pseudotypes. A much higher percentage of SARS-CoV-2–uninfected children and adolescents were positive for these antibodies compared with adults. This pattern may be due to the fact that children and adolescents generally have higher hCoV infection rates and a more diverse antibody repertoire, which may explain the age distribution of COVID-19 susceptibility. Science , this issue p. 1339 ; see also p. 1272

22 July 2020 in Nature
Verified
Journal Article
Closed access
PDF file
IMIan J. McGough
Ian J. McGough
LVLuca Vecchia
Luca Vecchia
BBBenjamin Bishop
Benjamin Bishop
TMTomas Malinauskas
Tomas Malinauskas
KBKaren Beckett
Karen Beckett
JVJean-Paul Vincent
Jean-Paul Vincent

8 January 2021 in eLife
Verified
Journal Article
Open access
IGIlaria Gori
Ilaria Gori
RGRoger George
Roger George
APAndrew G Purkiss
Andrew G Purkiss
SSStephanie Strohbuecker
Stephanie Strohbuecker
RRRebecca A Randall
Rebecca A Randall
CHCaroline S Hill
Caroline S Hill
Shprintzen–Goldberg syndrome (SGS) is a multisystemic connective tissue disorder, with considerable clinical overlap with Marfan and Loeys–Dietz syndromes. These syndromes have commonly been associated with enhanced TGF-β signaling. In SGS patients, heterozygous point mutations have been mapped to the transcriptional co-repressor SKI, which is a negative regulator of TGF-β signaling that is rapidly degraded upon ligand stimulation. The molecular consequences of these mutations, however, are not understood. Here we use a combination of structural biology, genome editing, and biochemistry to show that SGS mutations in SKI abolish its binding to phosphorylated SMAD2 and SMAD3. This results in stabilization of SKI and consequently attenuation of TGF-β responses, both in knockin cells expressing an SGS mutation and in fibroblasts from SGS patients. Thus, we reveal that SGS is associated with an attenuation of TGF-β-induced transcriptional responses, and not enhancement, which has important implications for other Marfan-related syndromes.

11 November 2024 in Nature Communications
Verified
Journal Article
Open access
PDF file
MBM. Teresa Bertran
M. Teresa Bertran
RWRobert Walmsley
Robert Walmsley
TCThomas Cummings
Thomas Cummings
IAIker Valle Aramburu
Iker Valle Aramburu
DBDonald J. Benton
Donald J. Benton
LWLouise J. Walport
Louise J. Walport
Peptidylarginine deiminase IV (PADI4, PAD4) deregulation promotes the development of autoimmunity, cancer, atherosclerosis and age-related tissue fibrosis. PADI4 additionally mediates immune responses and cellular reprogramming, although the full extent of its physiological roles is unexplored. Despite detailed molecular knowledge of PADI4 activation in vitro, we lack understanding of its regulation within cells, largely due to a lack of appropriate systems and tools. Here, we develop and apply a set of potent and selective PADI4 modulators. Using the mRNA-display-based RaPID system, we screen >1012 cyclic peptides for high-affinity, conformation-selective binders. We report PADI4_3, a cell-active inhibitor specific for the active conformation of PADI4; PADI4_7, an inert binder, which we functionalise for the isolation and study of cellular PADI4; and PADI4_11, a cell-active PADI4 activator. Structural studies with PADI4_11 reveal an allosteric binding mode that may reflect the mechanism that promotes cellular PADI4 activation. This work contributes to our understanding of PADI4 regulation and provides a toolkit for the study and modulation of PADI4 across (patho)physiological contexts.

19 May 2025 in Nature Microbiology
Verified
Journal Article
Open access
PDF file
HBHugo Belda
Hugo Belda
DBDavid Bradley
David Bradley
ECEvangelos Christodoulou
Evangelos Christodoulou
SNStephanie D. Nofal
Stephanie D. Nofal
MBMalgorzata Broncel
Malgorzata Broncel
MTMoritz Treeck
Moritz Treeck
Of 250 Plasmodium species, 6 infect humans, with P. falciparum causing over 95% of 600,000 annual malaria-related deaths. Its pathology arises from host cell remodelling driven by over 400 exported parasite proteins, including the FIKK kinase family. About one million years ago, a bird-infecting Plasmodium species crossed into great apes and a single non-exported FIKK kinase gained an export element. This led to a rapid expansion into 15–21 atypical, exported Ser/Thr effector kinases. Here, using genomic and proteomic analyses, we demonstrate FIKK differentiation via changes in subcellular localization, expression timing and substrate motifs, which supports an individual important role in host–pathogen interactions. Structural data and AlphaFold2 predictions reveal fast-evolving loops in the kinase domain that probably enabled rapid functional diversification for substrate preferences. One FIKK evolved exclusive tyrosine phosphorylation, previously thought absent in Plasmodium. Despite divergence of substrate preferences, the atypical ATP binding pocket is conserved and we identified a single compound that inhibits all FIKKs. A pan-specific inhibitor could reduce resistance development and improve malaria control strategies.

18 August 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
JHJoshua Hope
Joshua Hope
EPEmma Punch
Emma Punch
NCNicola J. Cook
Nicola J. Cook
MSMatthew R. Singer
Matthew R. Singer
DJDhira Joshi
Dhira Joshi
PCPeter Cherepanov
Peter Cherepanov
HIV-1 and other lentiviruses hijack the cellular chromatin-binding protein LEDGF/p75 to facilitate integration into active transcription units. However, the mechanism of chromatin engagement by lentiviral intasomes and the structural role of LEDGF/p75 in this process remain poorly understood. To address these gaps, we studied the activities of native HIV-1 preintegration complexes and in vitro-assembled lentiviral intasomes in the presence of chromatinized target DNA. While LEDGF/p75 was both essential and minimally sufficient to enhance lentiviral integration into chromatin containing histone H3 trimethylated on Lys36, it unexpectedly facilitated integration outside of the nucleosome core particles. LEDGF/p75 additionally inhibited integration into unmodified chromatin in a dose-dependent manner, promoting integration into naked DNA. To explore the structural foundation for these activities, we imaged maedi-visna virus intasomes saturated with LEDGF/p75 before and after strand transfer by cryogenic electron microscopy. The structures revealed that the host factor alters the target DNA binding platform of the lentiviral intasome, imposing significant constraints on the path and configuration of target DNA to impede nucleosome engagement. Our results establish the preference of lentiviral intasomes for linker DNA regions within H3K36Me3-enriched chromatin and show that LEDGF/p75 plays a specific structural role at the viral–host target DNA interface.